BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12693394)

  • 1. A Medicare prescription drug benefit: issues and options.
    Cubanski J
    Issue Brief (Commonw Fund); 2003 Apr; (618):1-8. PubMed ID: 12693394
    [No Abstract]   [Full Text] [Related]  

  • 2. State Medicaid prescription drug expenditures for Medicare-Medicaid dual eligibles: estimates of Medicaid savings and federal expenditures resulting from expanded Medicare prescription coverage.
    Dale SB; Verdier JM
    Issue Brief (Commonw Fund); 2003 Apr; (627):1-12. PubMed ID: 12685428
    [No Abstract]   [Full Text] [Related]  

  • 3. Continuing policy issues in Medicare prescription drug coverage.
    Cubanski J
    Issue Brief (Commonw Fund); 2004 Nov; (710):1-5. PubMed ID: 15597515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription drug coverage for people with Medicare.
    Stein N
    Issue Brief Cent Medicare Educ; 2002; 3(9):1-8. PubMed ID: 12516561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Medicare prescription drug benefit: focusing on coverage and cost.
    Cubanski J; Kline J
    Issue Brief (Commonw Fund); 2002 Apr; (538):1-6. PubMed ID: 11993504
    [No Abstract]   [Full Text] [Related]  

  • 7. Affordable prescription drugs--state and federal action.
    Ohio Nurses Rev; 2003 Aug; 78(7):4. PubMed ID: 15134064
    [No Abstract]   [Full Text] [Related]  

  • 8. SHIPS awarded 31.7 million dollars to help beneficiaries about new drug coverage.
    Miss RN; 2005; 67(2):17. PubMed ID: 16047853
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug coverage for Medicare beneficiaries: why protection may be in jeopardy.
    Briesacher B; Stuart B; Shea D
    Issue Brief (Commonw Fund); 2002 Jan; (505):1-8. PubMed ID: 11922051
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessing the impact of coverage gaps in the Medicare Part D drug benefit.
    Hudson N
    Find Brief; 2008 Apr; 11(3):1-3. PubMed ID: 18441611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of insurance type on prescription drug use and expenditures among elderly Medicare beneficiaries.
    Saleh SS; Weller W; Hannan E
    J Health Hum Serv Adm; 2007; 30(1):50-74. PubMed ID: 17557696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caught in between: prescription drug coverage of Medicare beneficiaries near poverty.
    Shea DG; Stuart BC; Briesacher B
    Issue Brief (Commonw Fund); 2003 Aug; (669):1-8. PubMed ID: 12926411
    [No Abstract]   [Full Text] [Related]  

  • 13. The new Medicare drug benefit: much ado about little?
    Pauly MV
    LDI Issue Brief; 2004; 9(4):1-6. PubMed ID: 15035261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Part D decisions: like other employers, many states are collecting a new federal subsidy for maintaining retiree drug coverage--but for many, that's not their "final answer".
    Burton R; Folkemer D
    State Legis; 2006 Sep; 32(8):26-7. PubMed ID: 16958187
    [No Abstract]   [Full Text] [Related]  

  • 15. Medicare spending on HMOs and stand-alone drug plans: what is it worth to beneficiaries?
    Austin BJ
    Find Brief; 2008 Nov; 11(8):1-3. PubMed ID: 19035029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Riding the rollercoaster: the ups and downs in out-of-pocket spending under the standard Medicare drug benefit.
    Stuart B; Briesacher BA; Shea DG; Cooper B; Baysac FS; Limcangco MR
    Health Aff (Millwood); 2005; 24(4):1022-31. PubMed ID: 16012142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription drug costs easier to swallow.
    State Legis; 2010 Apr; 36(4):10. PubMed ID: 20397320
    [No Abstract]   [Full Text] [Related]  

  • 19. Benefits and consequences for the poor and the disabled.
    Elliott RA; Majumdar SR; Gillick MR; Soumerai SB
    N Engl J Med; 2005 Dec; 353(26):2739-41. PubMed ID: 16382058
    [No Abstract]   [Full Text] [Related]  

  • 20. Private, individual drug coverage in the current Medicare market.
    Boccuti C; Moon M
    Policy Brief Commonw Fund; 2003 Oct; (679):1-10. PubMed ID: 14562796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.